The Neurochemistry of Depression: The Good, The Bad and The Ugly.

Asma Zaidi, Kami Pearson, Kimberley Beier, Thornton Mardis, Bryan Munoz

Journal: Missouri medicine 2024;121(1):68-75

PMID: 38404431

Abstract

A large constellation of experimental evidence suggests that neuroinflammation is involved in the onset of depression and neurodegenerative disorders. Many studies have shown impairments in tryptophan metabolism, the major pathway for the synthesis of serotonin, the mood regulating neurotransmitter. This article reviews the various metabolites generated in the competing pathways of tryptophan metabolism including the kynurenine pathway. Increased synthesis of the neurotoxic compound quinolinic acid occurs at the expense of the synthesis of the neuroprotective metabolite kynurenic acid. This shift in equilibrium plays a critical role in the induction of oxidative stress, neuroinflammation, and neurotoxicity. Sufficient protein intake with adequate amounts of tryptophan along with dietary antioxidants and flavonoids may offer protection against major depressive and neurodegenerative disorders.

Copyright 2024 by the Missouri State Medical Association.

Address: Research Associate, Kansas City University, Kansas City, Missouri.; Medical student, Kansas City University, Kansas City, Missouri.; Professor of Biochemistry, Kansas City University, Kansas City, Missouri.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.